Marshall Wace
QUIT icon

Marshall Wace’s Achieve Life Sciences QUIT Stock Holding History

Marshall Wace’s Portfolio QUIT Stock Details QUIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.6M Buy
3,770,313
+2,751,032
+270% +$13.1M 0.02% 633
2026
Q1 		$3M Hold
1,019,281
– – ﹤0.01% 1567
2025
Q4 		$5.07M Buy
1,019,281
+244,428
+32% +$1.07M ﹤0.01% 1150
2025
Q3 		$2.44M Buy
+774,853
New +$2.13M ﹤0.01% 1518

Other funds holding QUIT

Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TPG GP A
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
venBio Partners
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Propel Bio Management
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Marshall Wace's QUIT Position: Q2 2026 in Review

Marshall Wace increased its Achieve Life Sciences (QUIT) stake by 270% in Q2 2026, buying an estimated $13.1M and bringing the position to 3,770,313 shares worth $24.6M. The position accounts for 0.02% of the portfolio, ranked #633.

Marshall Wace first reported a position in QUIT in Q3 2025 and has held it in 4 quarters since. 112 funds tracked by Wall St. Rank hold QUIT as of Q2 2026.

  • Marshall Wace held 3,770,313 shares of Achieve Life Sciences worth $24.6M as of Q2 2026.
  • Marshall Wace bought 2,751,032 Achieve Life Sciences shares in Q2 2026, an estimated $13.1M.
  • Achieve Life Sciences made up 0.02% of Marshall Wace's portfolio in Q2 2026, its #633 holding.
  • Marshall Wace first reported a position in Achieve Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 112 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.